Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of recombinant batroxobin for hemostasis in posterior cervical and lumbar spine surgery
CTR20202352Phase 3Active
- Sponsor
- Shanghai Tenry Pharmaceutical Co., Ltd.
- Start
- Apr 2021
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant batroxobin in cervical osteoarthritis, lumbar spondylosis, sponsored by Shanghai Tenry Pharmaceutical Co., Ltd.. Started Apr 2021; status: active.
02
Drugs
recombinant batroxobin
03
Conditions
cervical osteoarthritislumbar spondylosis
Beyond the preview
Go deeper on CTR20202352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202352.